Pfizer, Inc.

Pfizer, Inc. is among the world’s largest Pharmaceuticals sector businesses in the world. Pfizer, Inc.’s employees generate $18.618B in profits on $49.098B of revenue. Global output in the Pharmaceuticals business will likely rise substantially over the next 10 years. Long-term economic growth may lift all boats, but Pfizer, Inc. is determined to remain a market leader. Sectoral leadership in the Pharmaceuticals segment takes dedication and consistency, but management seeks out-sized growth.

Pfizer, Inc.’s ticker symbol PFE has recently been trading near $25.69 a share. The Pfizer, Inc. corporate headquarters in New York NY predicts Pharmaceuticals profits will satisfy shareholders in search of risk-appropriate returns.

The significance of market volume is sometimes ignored, but with a total market capitalization of $180.299B ensures sufficient liquidity. With a beta of 0.89, the company is less volatile than the market as a whole. When the average equity moves lower, Pfizer, Inc. moves less aggressively.